Anti-Scl70 antibodies directed against an epitope of the topoisomerase enzyme (abbreviated anti-topoisomerase, ATA; seen in 15–20% of SSc) are conversely predictive of diffuse disease and found in ∼45% of those who progress with lung complications (Reveille et al., 2003). Here, ATM is linked to systemic sclerosis.